Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nephrotoxicity following single dose mithramycin therapy.

R G Benedetti, K J Heilman, P A Gabow

    American Journal of Nephrology
    |September 1, 1983
    PubMed
    Summary

    Mithramycin can cause kidney damage, even in a single dose, particularly in patients with existing kidney issues. This case highlights the risk of nephrotoxicity in cancer patients treated for hypercalcemia.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Relationships between respiratory sinus arrhythmia and stress in college students.

    Journal of behavioral medicine·2019
    Same author

    Atypical autonomic regulation, auditory processing, and affect recognition in women with HIV.

    Biological psychology·2013
    Same author

    Familial clustering of ruptured intracranial aneurysms in autosomal dominant polycystic kidney disease.

    American journal of kidney diseases : the official journal of the National Kidney Foundation·2001
    Same author

    Making a public hospital work.

    Health affairs (Project Hope)·2001
    Same author

    Diuretics versus angiotensin-converting enzyme inhibitors in autosomal dominant polycystic kidney disease.

    American journal of nephrology·2001
    Same author

    Progression of autosomal-dominant polycystic kidney disease in children.

    Kidney international·2001

    Area of Science:

    • Nephrology
    • Oncology
    • Pharmacology

    Background:

    • Mithramycin is a chemotherapy agent used to treat hypercalcemia.
    • Single-dose mithramycin is generally not associated with renal dysfunction.
    • Hypercalcemia is a common complication in patients with advanced cancers.

    Observation:

    • A patient with squamous cell carcinoma and obstructive uropathy presented with hypercalcemia.
    • The patient received a single dose of mithramycin at 25 micrograms/kg.
    • Nephrotoxicity was observed following mithramycin administration.

    Findings:

    • This case report details nephrotoxicity after a single dose of mithramycin.
    • Underlying renal impairment may increase the risk of mithramycin-induced kidney damage.
    • The patient had pre-existing renal impairment due to obstructive uropathy.

    Implications:

    • Clinicians should carefully assess renal function before administering mithramycin.
    • Patients with pre-existing renal impairment may require dose adjustments or alternative treatments.
    • This case underscores the potential nephrotoxic effects of mithramycin, even at standard doses.

    Related Experiment Videos